BioCardia Inc reports results for the quarter ended June 30 - Earnings Summary

BioCardia

12/08/2026 22:00

BioCardia Inc BCDA.OQ reported a quarterly adjusted loss of 13 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -40 cents.  The mean expectation of two analysts for the quarter was for a loss of 18 cents per share. Wall Street expected results to range from -19 cents to -17 cents per share.
Reported revenue was zero​; analysts expected zero. 
BioCardia Inc's reported EPS for the quarter was a loss of 13 cents​.
The company reported a quarterly loss of $1.61 million.
BioCardia Inc shares had fallen by 24.8% this quarter and lost 25.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 5.9% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated from LSEG data August 12 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.18
-0.13
Beat
Mar. 31 2026 
-0.16
-0.21
Missed
Dec. 31 2025 
-0.17
-0.06
Beat
Sep. 30 2025 
-0.23
-0.24
Missed